Tools and approaches to ensure quality of vaccines throughout the cold chain

Expert Review of Vaccines

Volumn 13, Issue 7, 2014, Pages 843-854

  Kartoglu, Umit ^a   Milstien, Julie ^b  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b Re Sidence Parc de Clementville   (France)

Author keywords

cold chain; cool water pack; supply chain; temperature monitoring device; temperature sensitivity; vaccine development; vaccine freezing; vaccine vial monitor

Indexed keywords

BACTERIAL VACCINE; BCG VACCINE; CHICKENPOX VACCINE; CHOLERA VACCINE; COOLING WATER; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; ICE; INACTIVATED VACCINE; INFLUENZA VACCINE; JAPANESE ENCEPHALITIS VACCINE; LIVE VACCINE; MEASLES VACCINE; MENINGITIS VACCINE; MENINGOCOCCUS VACCINE; ORAL POLIOMYELITIS VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; ROTAVIRUS VACCINE; SUBUNIT VACCINE; TETANUS TOXOID; TYPHOID VACCINE; VACCINE; VIRUS VACCINE; WART VIRUS VACCINE; YELLOW FEVER VACCINE;

DRUG LABELING; DRUG PACKAGING; DRUG QUALITY; DRUG STABILITY; DRUG STORAGE; FREEZING; HEALTH CARE ACCESS; HIGH TEMPERATURE; MONITOR; PRACTICE GUIDELINE; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; REFRIGERATOR; REVIEW; RISK ASSESSMENT; RISK MANAGEMENT; SHELF LIFE; STORAGE TEMPERATURE; TEMPERATURE MEASUREMENT; TEMPERATURE SENSITIVITY; THERMOMETER; THERMOREGULATION; THERMOSTABILITY; VACCINE COLD CHAIN; WORLD HEALTH ORGANIZATION; HEAT; HUMAN; IMMUNIZATION; IMMUNOLOGY; QUALITY CONTROL; TRAFFIC AND TRANSPORT;

DRUG STABILITY; DRUG STORAGE; FREEZING; HOT TEMPERATURE; HUMANS; IMMUNIZATION; QUALITY CONTROL; REFRIGERATION; TRANSPORTATION; VACCINES;

EID: 84902332168     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.2014.923761     Document Type: Review

References (92)

1. World Health Organization. State of the world's vaccines and immunization, Geneva 2009. Available from: www.whqlibdoc.who. int/publications/2009/9789241563864-eng. pdf
2. Arlington: public Broadcasting Service. Available from: www.pbs.org/wgbh/aso/databank/entries/dm79sp.html
3. World Health Organization. Poliomyelitis. Fact sheet No. 114, Geneva, April 2013. Available from: www.who.int/mediacentre/factsheets/fs114/en/
4. UNICEF, New York: Expanding immunization coverage. Available from: www.unicef.org/immunization/index-coverage.html
5. cdc.gov [Internet] Atlanta: Centers for disease control and prevention. Global immunization strategic framework 2011-2015. Available from: www.cdc.gov/globalhealth/gid/framework/framework.html
6. UNECA. Goal 4: Reduce child mortality. 2012. Available from: www1.uneca.org/Portals/mdgreports/2012/Goal04.pdf
7. unicef.org [Internet] New York: young child survival and development. Available from: www.unicef.org/childsurvival/index-40850. html
8. who.int [Internet] Geneva: World Health Organization. Number of countries having introduced Hib (containing) vaccines to date. Available from: www.who.int/nuvi/hib/Countries-Intro-HibV-Sep2012.ppt
9. reportlinker.org [Internet] Lyon: reportLinker corporate. marketview: universal pneumo vaccines. Available from: www.reportlinker.com/p0961710/ MarketVIEW-Universal-pneumo-vaccines. html
10. vaccinenewsdaily.com [Internet] Chicago: Vaccine News Daily. Haiti introduces rotavirus vaccine into routine immunization program. Available from: www. vaccinenewsdaily.com/vaccine-development/324490-haiti-introduces-rotavirus- vaccineinto-routine-immunization-program/
11. World Health Organization, Global vaccine action plan 2011-2020. Geneva 2013. Available from: www.who.int/iris/bitstream/10665/78141/1/9789241504980- eng.pdf
12. Levine OS, Bloom DE, Cherian T, et al. The future of immunisation policy, implementation, and financing. Lancet 2011;378(9789):439-48
13. World Health Organization. Children: reducing mortality. WHO Fact sheet no.178. 2012. Available from: www.who.int/mediacentre/factsheets/fs178/en/
14. Burton A, Monasch R, Lautenbach B, et al. WHO and UNICEF estimates of national infant immunization coverage: methods and processes. Bull World Health Organ 2009;87:535-41
15. United Nations/AGECC. Energy for a sustainable future: summary report and recommendations, 2010. New York. Available from: www.un.org/wcm/webdav/site/ climatechange/shared/Documents/AGECC%20summary%20report%5B1%5D.pdf
16. Kurzatkowski W, Kartoglu U, Staniszewska M, et al. Structural damages in adsorbed vaccines affected by freezing. Biologicals 2013;41(2):71-6
17. McColloster PJ. US vaccine refrigeration guidelines: loose links in the cold chain. Hum Vaccin 2011;7:574-5
18. Levinson DR. Vaccines for children program: vulnerabilities in vaccine management. Department of Health and Human Services, Office of Inspector General. 2012. OEI-04-10-00430 Available from: www.oig.hhs.gov/oei/reports/oei- 04-10-00430.pdf.
19. Wirkas T, Toikilik S, Miller N, et al. A vaccine cold chain freezing study in PNG highlights technology needs for hot climate countries. Vaccine 2007;25:691-7 (Pubitemid 44856107)
20. Matthias DM, Robertson J, Garrison MM, et al. Freezing temperatures in the vaccine cold chain: a systematic review. Vaccine 2007;25:3980-6. (Pubitemid 46616996)
21. Techathawat S, Varinsathien P, Rasdjarmrearnsook A, Tharmaphornpilas P. Exposure to heat and freezing in the vaccine cold chain in Thailand. Vaccine 2007;25: 1328-33 (Pubitemid 46027330)
22. Parenteral Drug Association (PDA). Guidance for temperature-controlled medicinal products: maintaining the quality of temperature-sensitive medicinal products through the transportation environment. Bethesda (MD) Parenteral Drug Association (PDA) PDA J Pharm Sci Technol 2007; Report No. 39
23. Afsar A, Kartoglu U. Vaccine stock management: guidelines for immunization and vaccine store managers. Geneva, 2006. WHO/IVB/06.12 Available from: www. whqlibdoc.who.int/hq/2006/WHO-IVB-06.12-eng.pdf
24. Burgess MA, McIntyre PB. Vaccines and the cold chain: is it too hot...or too cold? Med J Aust 1999;171:82 (Pubitemid 29358650)
25. Jeremijenko A, Kelly H, Sibthorpe B, Attewell R. Improving vaccine storage in general practice refrigerators. BMJ 1996;312:1651-2 (Pubitemid 26229456)
26. Bell KN, Hogue CJ, Manning C, Kendal AP. Risk factors for improper vaccine storage and handling in private provider offices. Pediatrics 2001;107:e100
27. Gazmararian JA, Oster NV, Green DC, et al. Vaccine storage practices in primary health care physician offices. Am J Prev Med 2002;23(4):246-53 (Pubitemid 36160496)
28. Nelson C, Froes P, Van Dyck AM, et al. Monitoring temperatures in the vaccine cold chain in Bolivia. Vaccine 2007;25: 433-7. (Pubitemid 44883219)
29. World Health Organization. Requirements for poliomyelitis (oral). WHO Expert committee on biological standardization technical report series 40th report. Geneva 1989.800:Annex1. Available from: www.whqlibdoc.who.int/trs/WHO- TRS-800-(part1).pdf
30. World Health Organization. Requirements for measles, mumps and rubella vaccines and combined vaccine (live). Expert committee on biological standardization technical report series 43rd report. Geneva 1992.840:Annex3. Available from: www.whqlibdoc.who.int/trs/WHO-TRS-840.pdf
31. World Health Organization. Requirements for yellow fever vaccine. Expert committee on biological standardization, technical report series 46th Report. Geneva 1998. 840:Annex2. Available from: www. whqlibdoc.who.int/trs/WHO-TRS-872. pdf
32. World Health Organization. Quality of the cold chain: WHO/UNICEF policy statement on the use of vaccine vial monitors in immunization services (WHO/V&B/99.18). Available from: www. whqlibdoc.who.int/hq/1999/WHO-V&B- 99.18.pdf
33. Zipursky S, Boualam L, Cheikh DO, et al. Assessing the potency of oral polio vaccine kept outside of the cold chain during a national immunization campaign in Chad. Vaccine 2011;29:5652-6.
34. Halm A, Yalcouye I, Kamissoko M, et al. Using oral polio vaccine beyond the cold chain: a feasibility study conducted during the national immunization campaign in Mali. Vaccine 2010;28:3467-72
35. World Health Organization. Getting started with vaccine vial monitors, Geneva 2002 (WHO/V&B/02.35). Available from: www. whqlibdoc.who.int/hq/2002/ WHO-V&B-02.35.pdf
36. Dietz V, Milstien JB, van Loon F, et al. Performance and potency of tetanus toxoid: implications for eliminating neonatal tetanus. Bull World Health Organ 1996; 74(6):619-28 (Pubitemid 27104124)
37. Dietz V, Galazka A, van Loon F, Cochi S. Factors affecting the immunogenicity and potency of tetanus toxoid: implications for the elimination of neonatal and non-neonatal tetanus as public health problems. Bull World Health Organ 1997;75(1):81-93 (Pubitemid 27204822)
38. Edstam JS, Dulmaa N, Tsendjav O, et al. Exposure of hepatitis B vaccine to freezing temperatures during transport to rural health centers in Mongolia. Prev Med 2004;39:384-8 (Pubitemid 38834028)
39. Chen D, Kristensen D. Opportunities and challenges of developing thermostable vaccines. Expert Rev Vaccines 2009;8: 547-57.
40. Jezek J, Chen D, Watson L, et al. A heat-stable hepatitis B vaccine formulation. Hum Vaccin 2009;5(8):529-35
41. Schöndorf I, Banzhoff A, Nicolay U, Diaz-Mitoma F. Overcoming the need for a cold chain with conjugated meningococcal Group C vaccine: a controlled, randomized, double-blind study in toddlers on the safety and immunogenicity of Menjugate-, stored at room temperature for 6 months. Vaccine 2007;25:1175-82 (Pubitemid 46027350)
42. Le Tailec D, Doucet D, Elouahabi A, et al. CervarixTM, the GSK HPV-16/HPV-18 AS04-adjuvanted cervical cancer vaccine, demonstrates stability upon long-term storage and under simulated cold chain break conditions. Hum Vaccin 2009;5: 467-74
43. Milstien J, Kartoglu U, Zaffran M. Temperature sensitivity of vaccines. Geneva: World Health Organization; 2006. Available from: www.whqlibdoc.who.int/ hq/2006/WHO-IVB-06.10-eng.pdf.
44. World Health Organization WPRO. Preventing mother-to-child transmission for hepatitis B. Operational Field Guidelines for delivery of the birth dose of Hepatitis B vaccines. Manila 2005.pp19-21. Available from: www.wpro.who.int/NR/ rdonlyres/B8D1C444-C7B9-43B2-95A2-16ED87C94B0B/0/HepBBirthDoseFieldGuidelines. pdf
45. World Health Organization. WHO-UNICEF policy statement on the implementation of vaccine vial monitors: the role of vaccine vial monitors in improving access to immunization. Geneva 2007 (WHO/IVB/07.04). Available from: www.who.int/immunization-standards/vaccine-quality/VVM-joint-statement-2007.pdf.
46. World Health Organization. Internet Geneva: WHO prequalified vaccines. Available from: www.who.int/immunization-standards/vaccine-quality/PQ-vaccine- list-en/en/index.html
47. World Health Organization. Assessing the programmatic suitability of vaccine candidates for WHO prequalification. Geneva 2012, WHO/IVB/12.10. Available from: www.apps.who.int/iris/bitstream/10665/76537/1/WHO-IVB-12.10-eng. pdf
48. World Health Organization. Guidelines on stability evaluation of vaccines. Expert committee on biological standardization, technical report series 57th report. Geneva 2006;962:annex3
49. Kartoglu U, Ganivet S, Guichard S, et al. Use of cool water packs to prevent freezing during vaccine transportation at the country level. PDA J Pharm Sci Technol 2009; 63(1):11-26.
50. Kartoglu U, Ozguler NK, Wolfson LJ, Kurzatkowski W. Validation of the shake test for detecting freeze damage to adsorbed vaccines. Bull World Health Organ 2010;88:624-31.
51. World Health Organization. Shake and tell-video article. Available from: www.vimeo. com/8381355
52. World Health Organization. Step by step shake test-educational/ instructional video. Available from: www.vimeo.com/8389435
53. Murhekar MV, Dutta S, Kapoor AN, et al. Frequent exposure to suboptimal temperatures in vaccine cold-chain system in India: results of temperature monitoring in 10 states. Bull World Health Organ 2013;91:906-13. Available from: www.who. int/bulletin/volumes/91/12/13-119974.pdf
54. ISO 3100:2009 Risk management-Principles and guidelines
55. ISO Guide 73:2009 Risk management-Vocabulary
56. ISO/IEC 31010:2009 Risk management-Risk management techniques
57. Vesper J. An overview of risk management process. In: Risk assessment and risk management in the pharmaceutical industry (Chapter5). PDA/Davis Healthcare International Publishing; 2006
58. Kaplan S, Garrick BJ. On the quantitative definition of risk. Risk Anal 1981;1:11-27 (Pubitemid 12121289)
59. Haimes YY. Total risk management. Risk Anal 1991;11(2):169-71
60. Stamatis DH. Failure mode and effect analysis. FMEA from theory to execution. American Society for Quality; 2003
61. Vesely WE, Goldberg FF, Roberts NH, Haasl DF. Fault tree handbook. US Nuclear Regulatory Commisssion; 1981. NUREG-0492
62. World Health Organization. Establishing and improving primary and intermediate vaccine stores. Geneva: 2002; WHO/V&B/02.34
63. Kartoglu U. Asilarin optimal etkinliginin saglanmasi: Etkin asi yonetimi uygulamalari (ensuring the optimal potency of vaccines : effective vaccine management practices). In: Badur S, Bakir M, editors. Asi Kitabi (book of vaccines). Akademi Publishing, Turkey; 2012. p. 169-89
64. Kartoglu U, Nelaj E, Maire D. Improving temperature monitoring in the vaccine cold chain at the periphery : an intervention study using a 30-day electronic refrigerator temperature logger (Fridge-tag). Vaccine 2010;28:4065-72
65. World Health Organization. WHO PQS prequalified devices and equipment E006 temperature monitoring devices. Internet Available from: www.apps.who.int/immunization-standards/vaccine-quality/pqs-catalogue/ categorypage.aspx?id-cat=35
66. World Health Organization. PQS performance specification for vaccine cold box. Geneva 2012 (WHO/PQS/E01/CB.01.3). Available from: www.apps.who. int/immunization-standards/vaccine-quality/pqs-catalogue/catdocumentation.aspx? id-cat=18
67. World Health Organization. PQS performance specification for vaccine carrier. Geneva 2010 (WHO/PQS/E01/VC.01.2). Available from: www.apps.who.int/ immunization-standards/vaccine-quality/pqs-catalogue/catdocumentation.aspx? id-cat=18
68. World Health Organization. Technical review of vaccine vial monitor implementation. 27 March 2002, Geneva (unpublished report). Available from: www. who.int/immunization-standards/vaccine-quality/report-technical-review-of-vvm- implementation.pdf
69. Baker P. Vaccine vial monitors: small labels with an immense impact. Case studies for global health. Alliance for case studies for global health. 2009; Available from: www. usp.org/sites/default/files/usp-pdf/EN/AUTMGHCaseStudies. pdf
70. Frost LJ, Reich MR. Vaccine vial monitors: access to devices. In: Access: how do good health technologies get to poor people in poor countries? (Chapter 7 Harvard Centre for population and development studies. 2008. Available from: www.accessbook.org/downloads/chapter-7-AccessBook.pdf
71. Kartoglu U. Temperature sensitivity of the diphtheria containing vaccines, In: Priti R, editor. Insight and control of infectious disease in global scenario. In Tech 2012. Available from: www.intechopen.com/books/insight- and-control-of-infectiousdisease-in-global-scenario/temperaturesensitivity-of- the-diptheriacontaining-vaccines
72. O'Donnell K. A year in the life of a vaccine (video). Extensio et Progressio, Authentic e-Learning and Global Learning Opportunities. Available from: www.vimeo. com/58148553
73. Kristensen D. Thermostability of vaccines and the controlled temperature chain. In: Technet Kuala Lumpur consultation report. WHO; Geneva, Switzerland: 2010. p. 6
74. Zaffran M, Dicko M, McCarney S, Lloyd J. Powering the cool chain: Addressing the challenges of vaccine delivery where it is needed most. Panel discussion at cold chain & temperature control distribution summit, May-June 2011. Available from: www. lanyrd.com/2011/coldchainonline/schedule/
75. Shelley D. Report of the Immunization Practice Advisory Committee (IPAC) to SAGE. Geneva, 2012. Available from: www. who.int/immunization/sage/meetings/ 2012/november/IPAC.pdf
76. Project Optimize. Delivering MenAfriVac using the Controlled Temperature Chain Approach. 2013. Available from: www.path. org/publications/files/TS-opt- menafrivac-photo-set.pdf
77. WHO. Temperature controlled chain (CTC). Available from: www.who.int/biologicals/areas/vaccines/controlled temperaturechain/en/
78. Zaffran M, Vandelaer J, Kristensen D, et al. The imperative for stronger vaccine supply and logistics systems. Vaccine 2013;31S: B73-80
79. EPELA, e-Pharmaceutical cold chain management. Available from: www.epela. net/epela-web/introduction.html
80. EPELA, e-VVM based vaccine management. Available from: www.epela.net/epela-web/evvm.html
81. Bishara R. Global perspectives in regulatory oversight. (video). Extensio et Progressio, Authentic e-Learning and Global Learning Opportunities. Available from: www.vimeo. com/51441317
82. iata.org [Internet] Geneva. International Air Transport Association. Perishables and pharma. Available from: www.iata.org/whatwedo/cargo/pharma/ Pages/index.aspx
83. ich.irg [Internet] Geneva: International Conference on Harmonization. www.ich. org/products/guidelines/quality/article/quality-guidelines.html
84. World Health Organization. Model guidance for the storage and transport of time-and temperature sensitive pharmaceutical products. WHO Expert committee on specifications for pharmaceutical preparations 45th report. WHO Technical Report Series. No.961;2011. Annex9
85. Health Canada. Guidelines for temperature control of drug products during storage and transportation (GUI-0069). Available from: www.hc-sc.gc.ca/dhp-mps/ alt-formats/pdf/compli-conform/gmp-bpf/docs/GUI-0069-eng.pdf
86. European Union. Good Distribution Practice of Medicinal Products for Human Use (2013/C 68/01). Available from: www. eur-lex.europa.eu/LexUriServ/ LexUriServ.do? uri=OJ:C:2013:068:0001:0014:EN:PDF
87. United States Pharmacopeia; Good storage and distribution practices for drug products. 2012
88. United States Pharmacopeia; Monitoring devices-time, temperature and humidity. 2009
89. United States Pharmacopeia; Good distribution practices-supply chain integrity. 2011
90. IATA. Air transport logistics for time-and temperature-sensitive healthcare products. IATA 2009. Available from: https://www. iata.org/publications/Pages/temperaturecontrol-regulations.aspx
91. Dellepiane N, Griffiths E, Milstien JB. New challenges in assuring vaccine quality. Bull World Health Organ 2000;78(2):155-62 (Pubitemid 30151599)
92. O'Donnell K. Changing the face of cold chain. Contract Pharma. 2011. Available from: www.contractpharma.com/issues/2011-11/view-advanced-degrees/ changingthe-face-of-cold-chain-management